Sun Pharmaceutical Reports Strong Q1 Growth Driven by India Business and Innovative Medicines
Sun Pharmaceutical Industries Ltd. has reported a 27% year-on-year increase in consolidated net profit for the quarter ended June 30, 2026, supported by strong revenue growth and improved operational performance. The company’s net profit attributable to owners rose to ₹2,894.79 crore, compared with ₹2,278.63 crore in the same quarter last year. The company’s consolidated revenue…
